loading
Dbv Technologies Adr stock is traded at $4.86, with a volume of 12,895. It is down -6.72% in the last 24 hours and up +10.58% over the past month. DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.
See More
Previous Close:
$5.21
Open:
$4.84
24h Volume:
12,895
Relative Volume:
0.08
Market Cap:
$100.96M
Revenue:
-
Net Income/Loss:
$-102.09M
P/E Ratio:
-4.6286
EPS:
-1.05
Net Cash Flow:
$-108.72M
1W Performance:
+16.39%
1M Performance:
+10.58%
6M Performance:
+33.94%
1Y Performance:
-40.21%
1-Day Range:
Value
$4.75
$4.9209
1-Week Range:
Value
$4.15
$5.30
52-Week Range:
Value
$2.2045
$8.318

Dbv Technologies Adr Stock (DBVT) Company Profile

Name
Name
Dbv Technologies Adr
Name
Phone
33(0)155427878
Name
Address
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Name
Employee
108
Name
Next Earnings Date
2024-07-29
Name
Latest SEC Filings
Name
DBVT's Discussions on Twitter

Compare DBVT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
DBVT
Dbv Technologies Adr
4.75 100.96M 0 -102.09M -108.72M -1.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
507.23 130.68B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
679.00 74.97B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
597.25 36.08B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
242.07 31.19B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
256.88 27.56B 3.32B -860.46M -1.04B -8.32

Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-04-23 Upgrade Societe Generale Hold → Buy
Dec-16-22 Downgrade Goldman Neutral → Sell
May-10-22 Downgrade Goldman Buy → Neutral
Sep-14-21 Upgrade Societe Generale Hold → Buy
Jan-22-21 Downgrade Societe Generale Hold → Sell
Nov-02-20 Upgrade Societe Generale Sell → Hold
Aug-06-20 Downgrade Societe Generale Buy → Sell
Aug-05-20 Reiterated H.C. Wainwright Buy
Mar-17-20 Downgrade Stifel Buy → Hold
Jan-09-20 Upgrade Stifel Hold → Buy
Dec-16-19 Initiated Citigroup Buy
Sep-05-19 Resumed Morgan Stanley Equal-Weight
Jun-17-19 Initiated Goldman Buy
Dec-20-18 Downgrade Barclays Overweight → Equal Weight
Dec-20-18 Downgrade BofA/Merrill Buy → Underperform
Dec-20-18 Downgrade Jefferies Buy → Hold
Dec-20-18 Downgrade Stifel Buy → Hold
Oct-31-17 Upgrade Societe Generale Sell → Hold
Oct-24-17 Downgrade Societe Generale Buy → Sell
Oct-23-17 Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-23-17 Initiated Deutsche Bank Buy
Mar-16-17 Upgrade Societe Generale Hold → Buy
Sep-26-16 Initiated JMP Securities Mkt Outperform
Dec-03-15 Initiated Barclays Overweight
Oct-23-15 Initiated BofA/Merrill Buy
View All

Dbv Technologies Adr Stock (DBVT) Latest News

pulisher
03:40 AM

DBV Technologies (NASDAQ:DBVT) Coverage Initiated by Analysts at StockNews.com - Defense World

03:40 AM
pulisher
12:35 PM

DBV Technologies’ SWOT analysis: peanut allergy patch stock faces crucial trials By Investing.com - Investing.com South Africa

12:35 PM
pulisher
Mar 13, 2025

DBV Technologies’ SWOT analysis: peanut allergy patch stock faces crucial trials - Investing.com India

Mar 13, 2025
pulisher
Mar 12, 2025

European Equities Traded in the US as American Depositary Receipts Lower Wednesday - TradingView

Mar 12, 2025
pulisher
Mar 11, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - TradingView

Mar 11, 2025
pulisher
Mar 10, 2025

European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading - TradingView

Mar 10, 2025
pulisher
Mar 06, 2025

DBV Technologies (NASDAQ:DBVT) Coverage Initiated at StockNews.com - Defense World

Mar 06, 2025
pulisher
Mar 04, 2025

European Equities Traded in the US as ADRs Fall in Tuesday Trading - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

JMP reiterates DBV Technologies stock with $10 target - Investing.com

Mar 04, 2025
pulisher
Mar 03, 2025

European Equities Traded in the US as American Depositary Receipts Surge Higher in Monday Trading - TradingView

Mar 03, 2025
pulisher
Feb 28, 2025

DBV Technologies (DBVT) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week - TradingView

Feb 28, 2025
pulisher
Feb 27, 2025

DBV Technologies (DBVT) to Release Earnings on Thursday - Defense World

Feb 27, 2025
pulisher
Feb 26, 2025

DBV Technologies (NASDAQ:DBVT) Earns Hold Rating from Analysts at StockNews.com - Defense World

Feb 26, 2025
pulisher
Feb 26, 2025

DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress - TradingView

Feb 26, 2025
pulisher
Feb 25, 2025

Can This Peanut Patch Help Children Safely Eat 3-4 Peanuts? New 5-Year Data Reveals Promising Results - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading - TradingView

Feb 25, 2025
pulisher
Feb 25, 2025

DBV Technologies’ SWOT analysis: peanut allergy patch stock faces funding hurdles - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

DBV Technologies' SWOT analysis: peanut allergy patch stock faces funding hurdles - Investing.com UK

Feb 25, 2025
pulisher
Feb 24, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - TradingView

Feb 24, 2025
pulisher
Feb 24, 2025

DBV Technologies (NASDAQ:DBVT) vs. Allogene Therapeutics (NASDAQ:ALLO) Critical Contrast - Defense World

Feb 24, 2025
pulisher
Feb 21, 2025

European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading - MSN

Feb 21, 2025
pulisher
Feb 20, 2025

DBV Technologies (NASDAQ:DBVT) Now Covered by StockNews.com - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

DBV Technologies (NASDAQ:DBVT) Stock Crosses Above 50-Day Moving AverageTime to Sell? - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - TradingView

Feb 19, 2025
pulisher
Feb 18, 2025

DBV Technologies stock holds firm with $10 target from JMP By Investing.com - Investing.com South Africa

Feb 18, 2025
pulisher
Feb 18, 2025

DBV Technologies stock holds firm with $10 target from JMP - Investing.com India

Feb 18, 2025
pulisher
Feb 18, 2025

DBV Technologies (NASDAQ:DBVT) Shares Cross Above Fifty Day Moving Average – Time to Sell? - Defense World

Feb 18, 2025
pulisher
Feb 11, 2025

DBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at StockNews.com - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading - MSN

Feb 10, 2025
pulisher
Feb 10, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - MSN

Feb 10, 2025
pulisher
Feb 07, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, End Week Up 3.2% - TradingView

Feb 07, 2025
pulisher
Feb 05, 2025

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading - TradingView

Feb 05, 2025
pulisher
Jan 28, 2025

European Equities Traded in the US as American Depositary Receipts Tread Water in Monday Trading - MSN

Jan 28, 2025
pulisher
Jan 25, 2025

DBV Technologies (NASDAQ:DBVT) Shares Cross Above 50-Day Moving AverageShould You Sell? - MarketBeat

Jan 25, 2025
pulisher
Jan 25, 2025

StockNews.com Begins Coverage on DBV Technologies (NASDAQ:DBVT) - Defense World

Jan 25, 2025
pulisher
Jan 21, 2025

Patch effective through 36 months in treating toddlers with peanut allergy - Healio

Jan 21, 2025
pulisher
Jan 14, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - MSN

Jan 14, 2025
pulisher
Jan 13, 2025

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - The Manila Times

Jan 13, 2025
pulisher
Jan 13, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - MSN

Jan 13, 2025
pulisher
Jan 13, 2025

DBV Technologies Reports H2 2024 Liquidity Contract Results: 440,957 Shares Traded - StockTitan

Jan 13, 2025

Dbv Technologies Adr Stock (DBVT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Dbv Technologies Adr Stock (DBVT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Mohideen Pharis
Chief Medical Officer
Nov 25 '24
Sale
0.57
565
322
111,110
Mohideen Pharis
Chief Medical Officer
Nov 22 '24
Sale
0.53
342
181
111,675
Mohideen Pharis
Chief Medical Officer
Nov 21 '24
Sale
0.54
2,350
1,269
112,017
Mohideen Pharis
Chief Medical Officer
Jul 29 '24
Sale
0.98
1,785
1,749
79,367
Mohideen Pharis
Chief Medical Officer
May 24 '24
Sale
1.36
660
898
81,152
Mohideen Pharis
Chief Medical Officer
May 22 '24
Sale
1.38
382
527
81,812
$76.39
price up icon 1.28%
$306.85
price up icon 0.37%
$19.42
price up icon 0.89%
$32.53
price down icon 0.80%
$98.38
price up icon 0.88%
biotechnology ONC
$253.17
price down icon 0.95%
Cap:     |  Volume (24h):